GRAMINEX L.L.C. breidt samenwerking met IDIPharma uit na publicatie klinisch onderzoek
SAGINAW, Mich.–(BUSINESS WIRE)– Graminex® LLC, producent van het niet-oplosbaar bloempollenextract (Flower Pollen Extracts™) Graminex®, kondigt met blijdschap aan zijn samenwerking met IDIPharma uit te breiden. Na afronding en publicatie van klinisch-wetenschappelijke onderzoeken die het gebruik van Graminex® Flower Pollen Extract™ als middel tegen chronische pijn in de bekken onderschrijft, zijn IDIPharma en Graminex overeengekomen hun klinisch onderzoek uit te breiden.
“Graminex® kijkt ernaar uit zijn relatie met IDIPharma uit te breiden. IDIPharma is producent van DEPROX® 500, dat niet-oplosbare Graminex® Flower Pollen Extract™ bevat. IDIPharma heeft bewezen buitengewoon toegewijd te zijn aan kwaliteit, door zijn klanten goed onderbouwde producten te leveren”, zei Justin E Ritter, wettelijke zaken.
GRAMINEX L.L.C. expands its partnership with IDIPharma after clinical study publication.
SAGINAW, Mich.–(BUSINESS WIRE)– Graminex® LLC, producer of Non-Solvent Graminex® Flower Pollen Extracts™, is pleased to announce the expansion of its partnership with IDIPharma. After completion and publication of clinical studies supporting the use of Graminex® Flower Pollen Extract™ for Prostate Pain and Chronic Pelvic Pain (CCP), IDIPharma and Graminex® have agreed to expand clinical research on Graminex® Flower Pollen Extract™.
“Graminex® looks forward to expanding its relationship with IDIPharma, producer of DEPROX® 500 containing Non-Solvent Graminex® Flower Pollen Extract™. IDIPharma has proven its outstanding commitment to quality by delivering substantiated products to its customers,” stated Justin E Ritter, Regulatory Affairs.
“IDIPharma is committed to solving gynecological, urological and andrological problems by its continued scientific collaboration within the medical community. Deprox® 500, which contains Non-Solvent Graminex® Flower Pollen Extract™, was the first Italian Supplement strongly focused on prostatitis. Deprox® is supported by clinical studies that underline the distinctiveness of its formulation and its real effectiveness in regards to the long standing problems of prostatitis,” stated Dora Arena, Ph.D.
About Graminex® LLC
Graminex® LLC is the leading producer of natural and solvent free Graminex® Flower Pollen Extract™. Graminex® directly owns and manages more than 8,500 acres of farmland in Northwest Ohio. Graminex’s® active raw ingredients are grown and processed for use in the dietary supplement, pharmaceutical, food and skincare industries. Graminex® markets clinically supported Flower Pollen Extracts, focusing on prostate care, urinary care, menopausal support, and skin care. Partnered with its distributors, retailers and manufacturers, Graminex® products are sold in more than 44 countries.
About IDI Integratori Dietetic Italiana S.r.l.
IDIPharma is a pioneer and leader in the Italian phyto-market, focusing on urological diseases. Each year IDIPharma sponsors several Italian and European Urological Congresses to increase the awareness of Deprox® through urologists and publicizing results of clinical studies containing Non-Solvent Graminex® Flower Pollen Extracts™.
For further information please contact Graminex® LLC Public Relations, Colleen E. May at (419) 278-1023 or e-mail at info@graminex.com. You may also visit www.graminex.com.
IDI Integratori Dietetici Italiani S.r.l., Dora Arena, Ph.D. at 39.095.445392 or email at dora.arena@idipharma.com You may also visit www.idipharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171030005045/en/
Contacts
Colleen E. May
Public Relations
Graminex L.L.C.
2-300 County Road C
Deshler, Ohio 43516
(419) 278-1023
or
Dora Arena, Ph.D.
IDI Integratori Dietetici Italiani S.r.l.
Via G. Mameli 12
95020 ACI BONACCORSI (CT)
Italy
+39.095.445392